 |
|
|
| |
SAFETY AND EFFICACY OF PEGINTERFERON LAMBDA-1a (LAMBDA) COMPARED WITH PEGINTERFERON ALFA-2a (ALFA-2a) IN HCV-INFECTED PATIENTS (G1/2/3) WITH COMPENSATED CIRRHOSIS: EMERGE PHASE 2b EFFICACY AND SAFETY RESULTS THROUGH WEEK 12
|
| |
| |
Reported by Jules Levin
22nd Conference of the Asian Pacific Association for the Study of the Liver (APASL 2012), Taipei International Convention Center, February 16-19, 2012
RODRIGUEZ-TORRES M,1 HILLSON J,2 LAWITZ E,3 VARGAS H,4 VIERLING J,5 HORGA A,6 GRAY T,2 XU D,2 LOPEZ-TALAVERA JC,6
1FUNDACION DE INVESTIGACION, SAN JUAN, PUERTO RICO; 2ZYMOGENETICS/BMS, SEATTLE, WA, USA; 3ALAMO MEDICAL RESEARCH, SAN ANTONIO, TX, USA; 4 MAYO CLINIC, PHOENIX, AZ, USA; 5BAYLOR COLLEGE OF MEDICINE, HOUSTON, TX, USA; 6BRISTOL-MYERS SQUIBB, WALLINGFORD, CT, USA
|
| |
|
|
|
|
|
